Booster of plerixafor can be successfully used in addition to chemotherapy-based regimen to rescue stem cell mobilization failure.
作者:
主题词
成年人(Adult);抗原, CD34(Antigens, CD34);抗肿瘤联合化疗方案(Antineoplastic Combined Chemotherapy Protocols);苄胺类(Benzylamines);女(雌)性(Female);造血干细胞动员(Hematopoietic Stem Cell Mobilization);造血干细胞移植(Hematopoietic Stem Cell Transplantation);杂环化合物(Heterocyclic Compounds);人类(Humans);男(雄)性(Male);中年人(Middle Aged);受体, CXCR3(Receptors, CXCR3);挽救疗法(Salvage Therapy);治疗结果(Treatment Outcome);青年人(Young Adult)
PMID
21183878
发布时间
2021-12-03
- 浏览10
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文